Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07461350 · ClinicalTrials.gov registry record
Stimulant and Polysubstance Use, Inflammation, and Sex Effects on Myocardial Disease in HIV
A clinical trial, sponsored by University of California, San Francisco.
- Not yet
- Registry status
- 400
- Enrollment target
NCT07461350: Clinical Trial study, sponsored by University of California, San Francisco.
NCT07461350 is a clinical trial that has not yet begun recruiting, run by University of California, San Francisco. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07461350 has not yet begun recruiting, sponsored by University of California, San Francisco.
- NOT YET RECRUITING
- Registry status
- 400 participants
- Enrollment target
Study Summary
This observational research study is studying how substance use impacts scarring and inflammation of the heart. This study involves one study visit for a cardiac MRI.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2026-06-22 |
| Est. Completion | 2030-03-31 |
What is known before NCT07461350 opens enrollment
NCT07461350 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT07461350 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07461350 about?
NCT07461350 is a clinical study titled "Stimulant and Polysubstance Use, Inflammation, and Sex Effects on Myocardial Disease in HIV". This observational research study is studying how substance use impacts scarring and inflammation of the heart. This study involves one study visit for a cardiac MRI.
What is the current status of trial NCT07461350?
This trial is currently not yet recruiting. The enrollment target is 400 participants. The study started on 2026-06-22. Estimated completion is 2030-03-31.
Who is sponsoring clinical trial NCT07461350?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI